Home / Pharma Healthcare / China Ion Channel Modulators Market Research Report 2016

China Ion Channel Modulators Market Research Report 2016

  • Id : RNR-22235
  • Category : Pharma Healthcare
  • Publish Date : 11-Oct
  • Pages : 118
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Ion Channel Modulators
Revenue, means the sales value of Ion Channel Modulators

This report studies Ion Channel Modulators in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
    AstraZeneca (UK)
    Aurora Biomed, Inc. (Canada)
    CalciMedica, Inc. (US)
    Cellectricon AB (Sweden)
    Convergence Pharmaceuticals Limited (UK)
    Cytocentrics AG (Germany)
    Evotec AG (Germany)
    flyion GmbH (Germany)
    GlaxoSmithKline Plc. (UK)
    Neusentis, Inc. (US)
    Nanion Technologies GmbH (Germany)
    NeuroSearch A/S (Denmark)
    Novartis AG (Switzerland)
    Parion Sciences, Inc. (US)
    Pfizer, Inc. (US)
    Sanofi (France)
    Targacept, Inc. (US)
    Xention Limited (UK)
    Zalicus, Inc. (US)

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by Application, this report focuses on consumption, market share and growth rate of  Ion Channel Modulators in each application, can be divided into
    Application 1
    Application 2
    Application 3